We are just getting a study going at MD Anderson Cancer Center and Stanford to prove this is feasible. For breast cancer, we hope in the future to be able to replace surgery with a RITA needle-stick. We are conducting a study right now at MD Anderson to show this is feasible. The market for cancer is obviously very large. Cancer is the second-leading cause of death, second only to cardiovascular disease.
Cancer becomes a bigger and bigger problem as the patient population ages.
So the incidence and awareness of cancer is only growing. But frankly, for our company it isn t necessarily changes in the marketplace that really represent the biggest opportunity, it s just the fact that there are so many patients with this terrible disease who could avail themselves of the better option that RITA provides. We really set out to hire and have achieved hiring some of the best and brightest folks in the industry. My executive team is made up of people with terrific large company experience, as well as start-up experience, small company experience. They have experienced this kind of rapid growth, so we ve brought in the people who really have the experience and knowledge to manage that kind of rapid growth, and we ve brought in the financial resources as well to allow us to fund that growth.